All In MedTech

Device Trial Radar · NCT01712191

Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant

Last checked: Nov 20, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

128

Actual

Start

Jan 2011

Primary completion

Dec 2013

Study completion Mar 2016

Sponsor

Lead sponsor
Phoenix KineticsNot on our public-company list
Sponsor type
Industry
First posted
Oct 23, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 35 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multi-center, open label, non-randomized study, evaluating the treating of medial meniscus deficiency with the NUsurface Meniscus Implant.

Conditions

  • Meniscus; Degeneration
  • Osteoarthritis, Knee

Interventions

  • NUsurface Meniscus ImplantDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Knee injury and Osteoarthritis Outcome Score (KOOS)Time frame: 24 Months

Locations

10 sites in 6 countries. Site status is shown where the registry gives one.

  • AZ Monica

    Antwerp, Belgium

  • Ghent University Hospital

    Ghent, Belgium

  • Sporthopaedicum Berlin

    Berlin, Germany

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.